A Phase III Study of JSKN016 Versus Treatment of Physician's Choice in Patients With Triple-Negative Breast Cancer Who Have Failed Standard of Care
Clinical trial NCT07533123 · RECRUITING
Trial details
- NCT number
- NCT07533123
- Sponsor
- Jiangsu Alphamab Biopharmaceuticals Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-17
- Primary completion
- 2029-03-17
- Enrollment
- 364
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.